3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Liver Neoplasms
1
Glioma
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Advanced Breast Cancer
1
Interventions
pembrolizumab
7
Nivolumab
7
Specimen Handling
6
Mitomycin
6
Magnetic Resonance Spectroscopy
6
Capecitabine
6
Radiotherapy
5
Fluorouracil
4
Drug Therapy
4
Biopsy
4
Radiation
3
Paclitaxel
3
Ipilimumab
3
Fluorodeoxyglucose F18
3
Carboplatin
3
dehydroftorafur
2
atezolizumab
2
aldesleukin
2
Tomography, X-Ray Computed
2
Sigmoidoscopy
2
Radiotherapy, Intensity-Modulated
2
Proctoscopy
2
Mitozytrex
2
Colonoscopy
2
CTLA-4 Antigen
2
Adoptive Transfer
2
trastuzumab deruxtecan
1
spartalizumab
1
enzalutamide
1
entinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Ritonavir
×
1 year
×
Clear all
No trials found.